Alcon Canada Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2014) 448 F.T.R. 96 (FC)

This document cites

• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
• Fournier Pharma Inc. et al. v. Canada (Minister of Health) et al., (2012) 413 F.T.R. 277 (FC)
• Alcon Canada Inc. et al. v. Apotex Inc. et al., (2012) 433 F.T.R. 1 (FC)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)



See all quotations

• Ndima v. Winnipeg Housing Rehabilitation Corp. et al., (2011) 430 N.R. 397 (Motion)
• Dimplex North America Ltd. v. CFM Corp., 2006 FC 586
• AB Hassle v. Can., (2000) 256 N.R. 172 (FCA)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., (2008) 323 F.T.R. 56 (FC)
• Halford et al. v. Seed Hawk Inc. et al., 2004 FC 88
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Novopharm Ltd. v. Eli Lilly & Co., (2010) 376 F.T.R. 227 (FC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Wellcome Fdn. v. Apotex, (1991) 47 F.T.R. 81 (TD)
• Apotex Inc. v. Wellcome Fdn., (1998) 145 F.T.R. 161 (TD)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2005) 285 F.T.R. 1 (FC)
• Procter & Gamble Pharmaceuticals Canada Inc. et al. v. Canada (Minister of Health) et al., 2002 FCA 290
• Eurocopter v. Bell Helicopter Textron Canada Ltd. et al., (2013) 449 N.R. 111 (FCA)
• Monsanto Co. v. Commissioner of Patents, (1979) 28 N.R. 181 (SCC)
• Wyeth Canada et al. v. ratiopharm inc. et al., 2007 FCA 264
• GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., (2011) 385 F.T.R. 157 (FC)
• Merck & Co. et al. v. Apotex Inc. et al., 2005 FC 755
• Burton Parson Chemicals Inc. et al. v. Hewlett-Packard (Canada) Ltd. et al., (1974) 3 N.R. 553 (SCC)
• Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2013) 441 F.T.R. 72 (FC)
• Pfizer Canada Inc. et al. v. Pharmascience Inc. et al., (2013) 427 F.T.R. 6 (FC)
• Schering-Plough Canada Inc. et al. v. Pharmascience Inc. et al., 2009 FC 1128
• ratiopharm inc. v. Pfizer Ltd., (2009) 350 F.T.R. 250 (FC)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 1023
• Pioneer Hi-Bred Ltd. v. Commissioner of Patents, (1989) 97 N.R. 185 (SCC)
• Sanofi-Aventis Canada Inc. v. ratiopharm Inc. et al., 2010 FC 230
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2007) 361 N.R. 308 (FCA)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2011) 400 F.T.R. 164 (FC)